Enhanced microparticles in ventricular assist device patients predict platelet, leukocyte and endothelial cell activation

Interactive Cardiovascular and Thoracic Surgery

Volumn 11, Issue 2, 2010, Pages 133-137

  Diehla, Philipp ^a   Alekera, Miriam ^a   Helbinga, Thomas ^a   Sossonga, Verena ^a   Beyersdorfb, Friedhelm ^a   Olschewskic, Manfred ^a   Bodea, Christoph ^a   Mosera, Martin ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Microparticles; Platelet activation; Thrombotic complications; Ventricular assist devices

Indexed keywords

ADULT; ARTICLE; BLOOD CLOTTING; CELL ACTIVATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIAL MICROPARTICLE; ENDOTHELIUM CELL; EXTRACORPOREAL OXYGENATION; FEMALE; HEART ASSIST DEVICE; HUMAN; INFLAMMATION; LEUKOCYTE ACTIVATION; LEUKOCYTE COUNT; LEUKOCYTE MICROPARTICLE; MALE; PLATELET MICROPARTICLE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; THROMBOCYTE ACTIVATION; VENTRICULAR ASSIST DEVICE; AGED; BLOOD; CASE CONTROL STUDY; FLOW CYTOMETRY; GERMANY; HEMORRHAGE; LEUKOCYTE; MEMBRANE MICROPARTICLE; MIDDLE AGED; PATHOLOGY; RISK ASSESSMENT; RISK FACTOR; THROMBOCYTE; THROMBOSIS;

ADULT; AGED; BLOOD COAGULATION; BLOOD PLATELETS; CASE-CONTROL STUDIES; CELL-DERIVED MICROPARTICLES; ENDOTHELIAL CELLS; FEMALE; FLOW CYTOMETRY; GERMANY; HEART-ASSIST DEVICES; HEMORRHAGE; HUMANS; LEUKOCYTES; MALE; MIDDLE AGED; PLATELET ACTIVATION; RISK ASSESSMENT; RISK FACTORS; THROMBOSIS;

EID: 77957329355     PISSN: 15699293     EISSN: None     Source Type: Journal    
DOI: 10.1510/icvts.2010.232603     Document Type: Article

References (15)

1. Heilmann C, Geisen U, Benk C, Berchtold-Herz M, Trummer G, Schlensak C, Zieger B, Beyersdorf F. Haemolysis in patients with ventricular assist devices: major differences between systems. Eur J Cardiothorac Surg 2009;36:580-584.
2. Loebe M, Koster A, Sanger S, Potapov EV, Kuppe H, Noon GP, Hetzer R. Inflammatory response after implantation of a left ventricular assist device: comparison between the axial flow MicroMed DeBakey VAD and the pulsatile Novacor device. Asaio J 2001;47:272-274.
3. Bluestein D. Research approaches for studying flow-induced thromboembolic complications in blood recirculating devices. Expert Rev Med Devices 2004;1:65-80.
4. Hugel B, Martinez MC, Kunzelmann C, Freyssinet JM. Membrane microparticles: two sides of the coin. Physiology (Bethesda) 2005;20:22-27.
5. Mackman N. On the trail of microparticles. Circ Res 2009;104:925-927.
6. Diehl P, Nagy F, Sossong V, Helbing T, Beyersdorf F, Olschewski M, Bode C, Moser M. Increased levels of circulating microparticles in patients with severe aortic valve stenosis. Thromb Haemost 2008;99:711-719.
7. Klovaite J, Gustafsson F, Mortensen SA, Sander K, Nielsen LB. Severely impaired von Willebrand factor-dependent platelet aggregation in patients with a continuous-flow left ventricular assist device (HeartMate II). J Am Coll Cardiol 2009;53:2162-2167.
8. Hathcock JJ. Flow effects on coagulation and thrombosis. Arterioscler Thromb Vasc Biol 2006;26:1729-1737.
9. Dewald O, Fischlein T, Vetter HO, Schmitz C, Godje O, Gohring P, Reichart B. Platelet morphology in patients with mechanical circulatory support. Eur J Cardiothorac Surg 1997;12:634-641.
10. Baker LC, Davis WC, Autieri J, Watach MJ, Yamazaki K, Litwak P, Wagner WR. Flow cytometric assays to detect platelet activation and aggregation in device-implanted calves. J Biomed Mater Res 1998;41:312-321.
11. Del Principe D, Frega G, Savini I, Catani MV, Rossi A, Avigliano L. The plasma membrane redox system in human platelet functions andplatelet-leukocyte interactions. Thromb Haemost 2009;101:284-289.
12. Ankersmit HJ, Tugulea S, Spanier T, Weinberg AD, Artrip JH, Burke EM, Flannery M, Mancini D, Rose EA, Edwards NM, Oz MC, Itescu S. Activation-induced T-cell death and immune dysfunction after implantation of left-ventricular assist device. Lancet 1999;354:550-555.
13. Khan NA, Butany J, Zhou T, Ross HJ, Rao V. Pathological findings in explanted prosthetic heart valves from ventricular assist devices. Pathology 2008;40:377-384.
14. Mesri M, Altieri DC. Endothelial cell activation by leukocyte microparticles. J Immunol 1998;161:4382-4387.
15. Klinkner DB, Densmore JC, Kaul S, Noll L, Lim HJ, Weihrauch D, Pritchard KA Jr, Oldham KT, Sander TL. Endothelium-derived microparticles inhibit human cardiac valve endothelial cell function. Shock 2006; 25:575-580.